204 related articles for article (PubMed ID: 19615383)
1. A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy.
Billy F; Ribba B; Saut O; Morre-Trouilhet H; Colin T; Bresch D; Boissel JP; Grenier E; Flandrois JP
J Theor Biol; 2009 Oct; 260(4):545-62. PubMed ID: 19615383
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
3. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins.
Plank MJ; Sleeman BD; Jones PF
J Theor Biol; 2004 Aug; 229(4):435-54. PubMed ID: 15246783
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic gene therapy of cancer: current status and future prospects.
Persano L; Crescenzi M; Indraccolo S
Mol Aspects Med; 2007 Feb; 28(1):87-114. PubMed ID: 17306361
[TBL] [Abstract][Full Text] [Related]
5. Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells.
Ou-Yang F; Lan KL; Chen CT; Liu JC; Weng CL; Chou CK; Xie X; Hung JY; Wei Y; Hortobagyi GN; Hung MC
Cancer Res; 2006 Jan; 66(1):378-84. PubMed ID: 16397252
[TBL] [Abstract][Full Text] [Related]
6. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
7. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
8. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
9. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.
Cuevas I; Boudreau N
Adv Cancer Res; 2009; 103():25-42. PubMed ID: 19854351
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
[TBL] [Abstract][Full Text] [Related]
12. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
Dutour A; Rigaud M
Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
Luo X; Slater JM; Gridley DS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on lymphangiogenesis and angiogenesis in cancer.
Holopainen T; Bry M; Alitalo K; Saaristo A
J Surg Oncol; 2011 May; 103(6):484-8. PubMed ID: 21480240
[TBL] [Abstract][Full Text] [Related]
15. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
[TBL] [Abstract][Full Text] [Related]
16. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
Rak J; Yu JL
Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
Sato Y
Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
19. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
20. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
De Bock K; Cauwenberghs S; Carmeliet P
Curr Opin Genet Dev; 2011 Feb; 21(1):73-9. PubMed ID: 21106363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
